Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Beginning Cash Balance (2020 - 2025)

Historic Beginning Cash Balance for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $63.9 million.

  • Burning Rock Biotech's Beginning Cash Balance fell 2709.31% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.0 million, marking a year-over-year decrease of 1884.81%. This contributed to the annual value of $84284.0 for FY2024, which is 3532.58% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Beginning Cash Balance is $63.9 million, which was down 2709.31% from $72.9 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Beginning Cash Balance registered a high of $327.2 million during Q2 2021, and its lowest value of $63.9 million during Q3 2025.
  • For the 5-year period, Burning Rock Biotech's Beginning Cash Balance averaged around $153.9 million, with its median value being $110.8 million (2023).
  • As far as peak fluctuations go, Burning Rock Biotech's Beginning Cash Balance skyrocketed by 53421.84% in 2021, and later plummeted by 5701.72% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Beginning Cash Balance (Quarter) stood at $258.9 million in 2021, then dropped by 19.4% to $208.7 million in 2022, then crashed by 57.02% to $89.7 million in 2023, then fell by 23.89% to $68.3 million in 2024, then dropped by 6.36% to $63.9 million in 2025.
  • Its last three reported values are $63.9 million in Q3 2025, $72.9 million for Q2 2025, and $72.0 million during Q1 2025.